260 related articles for article (PubMed ID: 15951858)
1. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
2. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
3. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
[TBL] [Abstract][Full Text] [Related]
5. nm23-H1 gene expression in ovarian tumors--a potential tumor marker.
Kapitanovic S; Spaventi R; Vujsic S; Petrovic Z; Kurjak A; Pavelic ZP; Gluckman JL; Stambrook PJ; Pavelic K
Anticancer Res; 1995; 15(2):587-90. PubMed ID: 7763042
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
Kuo JY; Chiang H; Chen KK; Chang LS
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma].
Jiang Y; He A; Xia S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Aug; 18(4):209-11, 254. PubMed ID: 8697510
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
10. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
11. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
Li Y; Wu F; Gong W
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):177-9. PubMed ID: 11955409
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
13. Nm23 and cathepsin D expression in laryngeal carcinomas.
Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
[TBL] [Abstract][Full Text] [Related]
14. Nm23 protein expression in thyroid neoplasms.
Royds JA; Silcocks PB; Rees RC; Stephenson TJ
Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792
[TBL] [Abstract][Full Text] [Related]
15. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
18. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
